Technetium Tc 99m Sestamibi (MALLINCKRODT NUCLEAR MEDICINE LLC)


Welcome to the PulseAid listing for the Technetium Tc 99m Sestamibi drug offered from MALLINCKRODT NUCLEAR MEDICINE LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: MALLINCKRODT NUCLEAR MEDICINE LLC
NON-PROPRIETARY NAME: Technetium Tc 99m Sestamibi
SUBSTANCE NAME: TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2011-10-31
END MARKETING DATE: 0000-00-00


Technetium Tc 99m Sestamibi HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTechnetium Tc 99m Sestamibi from MALLINCKRODT NUCLEAR MEDICINE LLC
LABELER NAME: MALLINCKRODT NUCLEAR MEDICINE LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/mL)
START MARKETING DATE: 2011-10-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69945-092_c4c9366f-0da2-4079-84a9-185fd7e49e26
PRODUCT NDC: 69945-092
APPLICATION NUMBER: ANDA078098

Other TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AnazaoHealth CorporationSestamibi
Lantheus Medical Imaging, Inc.Cardiolite
MALLINCKRODT NUCLEAR MEDICINE LLCTechnetium Tc 99m Sestamibi